Rubicon™ 18 H74939239018150Recalls & reported problems
Boston Scientific Corporation · Support Catheter · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 08714729832164), received between Feb 12, 2020 and Jan 27, 2026 — classified as 1 injury, 4 malfunctions.
The most frequently reported specific device problem is “Entrapment of Device” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Entrapment of Device2
- Material Deformation2
- Break1
- Burst Container or Vessel1
- Unsealed Device Packaging1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
- No Consequences Or Impact To Patient1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 27, 2026Entrapment of Device
IT WAS REPORTED THAT DEVICE ENTRAPMENT OCCURRED. THE TARGET LESION WAS LOCATED IN AN ARTERY OF LOWER EXTREMITY. A 150CM RUBICON CATHETER-GUIDE WAS SELECTED FOR USE. DURING THE PROCEDURE, THE CATHETER AND THE GUIDE WIRE WERE ENTANGLED WITH EACH OTHER. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24191355 ↗MalfunctionMar 19, 2025Burst Container or Vessel; Material Deformation; Burst Container or Vessel; Material Deformation
IT WAS REPORTED THAT SHAFT BURST OCCURRED. THE 65% STENOSED TARGET LESION WAS LOCATED IN THE MILD TORTUOUS AND MODERATELY CALCIFIED ANTERIOR TIBIAL ARTERY. A 150 CM RUBICON 18 WAS USED FOR PROCEDURE. DURING THE PROCEDURE, THE WIRE WAS REMOVED FROM THE CATHETER TO TAKE A SHOT. A 3CC SYRINGE WAS CONNECTED TO THE CATHETER, AND UPON INJECTION, THE DISTAL TO THE HUB PART OF THE CATHETER STARTED TO BUBBLE AND EVENTUALLY POPPED OPEN AND BURST, SPRAYING CONTRAST. THE DEVICE WAS REMOVED INTACT, AND THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21644988 ↗InjuryApr 18, 2024Break; Material Deformation; Break; Material Deformation
IT WAS REPORTED THAT CATHETER BREAK OCCURRED AND DETACHED PIECE WAS REMOVED THROUGH SNARING. THE MORE THAN 80% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND SEVERELY CALCIFIED VESSEL OF THE LEFT LOWER EXTREMITY. A 150CM RUBICON 18 CATHETER GUIDE WAS SELECTED FOR USE IN A LEFT LEG EXTREMITY ARTERIOGRAM. DURING THE PROCEDURE, THE RUBICON WAS ADVANCED PAST THE GUIDEWIRE AND RESISTANCE WAS MET. UPON PULLING BACK, THE CATHETER WAS KINKED. RUBICON CATHETER WAS TUGGED, AND IT WAS NOTED THAT THE CATHETER DETACHED AT THE SECOND RADIOPAQUE (RO) MARKER. THE REMAINDER OF THE CATHETER WAS REMOVED, AND THE DETACHED PIECE WAS SUCCESSFULLY RETRIEVED USING A NON-BOSTON SCIENTIFIC (BSC) SNARE KIT. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE WITHOUT FURTHER ISSUES. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19130526 ↗MalfunctionAug 24, 2020Unsealed Device Packaging; Unsealed Device Packaging
IT WAS REPORTED THAT THE DEVICE WAS CONTAMINATED. THE TARGET LESION WAS LOCATED IN THE SUPERFICIAL FEMORAL ARTERY. A 150CM RUBICON 18 WAS SELECTED FOR USE. DURING UNPACKING, IT WAS NOTED THAT THE BOTTOM OF THE PACKAGE WAS NOT SEALED AND THE DEVICE BECAME CONTAMINATED. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND PATIENT WAS STABLE POST PROCEDURE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10443366 ↗MalfunctionFeb 12, 2020Entrapment of Device; Entrapment of Device
REPORTABLE BASED ON DEVICE ANALYSIS COMPLETED ON 21JAN2020. IT WAS REPORTED THAT A GUIDEWIRE AND CATHETER ENTRAPMENT OCCURRED. THE TARGET LESION WAS LOCATED IN THE RIGHT POSTERIOR TIBIAL ARTERY. A RUBICON WAS SELECTED FOR USE OVER A V18 GUIDEWIRE. DURING ATTEMPTS TO CROSS THE LESION, THE RUBICON AND V18 GUIDEWIRE BECAME ENTRAPPED WITH EACH OTHER. THE V18 GUIDEWIRE COULD NOT BE REMOVED FROM THE RUBICON AND THE DEVICES WERE REMOVED TOGETHER AS ONE UNIT. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO COMPLICATIONS REPORTED AND THE PATIENT WAS STABLE POST PROCEDURE. HOWEVER, DEVICE ANALYSIS REVEALED SEPARATION AT 12CM FROM THE TIP.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9700262 ↗
Other CATHETER, PERCUTANEOUS devices
- WATCHMAN FXD Curve™ Access System M635TU80020Boston Scientific Corporation · Catheter, percutaneous1 recall47 deaths654 reports
- NA C315HIS02Medtronic, Inc. · Catheter, percutaneous1 recall369 reports
- WATCHMAN TruSteer™ Access System M635TU90050Boston Scientific Corporation · Catheter, percutaneous1 recall28 deaths302 reports
- Guidezilla™ II H7493933515060Boston Scientific Corporation · CATHETER, PERCUTANEOUS1 recall3 deaths278 reports
- Velocity Delivery Microcatheter VEL160STR-APenumbra, Inc. · CATHETER, PERCUTANEOUS297 reports
- Guidezilla™ H7493924215050Boston Scientific Corporation · CATHETER, PERCUTANEOUS294 reports
- WATCHMAN™ TruSeal™ Access System M635TU70020Boston Scientific Corporation · Catheter, percutaneous1 recall11 deaths217 reports
- Lantern Delivery Catheter PXSLIMLAN135T45Penumbra, Inc. · CATHETER, PERCUTANEOUS220 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page